Clinical Trial Update: Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

View source ↗

Summary

Clinical trial update describing a study using liquid biopsy tracking in immunotherapy-treated stage IV melanoma; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Metastatic Melanoma | Status: NOT_YET_RECRUITING